-
Spatially resolved transcriptomics: advances and applications
Spatially resolved transcriptomics stands at the forefront of molecular biology and bioinformatics, merging the precision of genetic expression analysis with the complexity of spatial patterning. This confluence has been pivotal…
-
Minor clone of del(17p) as a predictor for relapse in multiple myeloma patients: A study by Jian Cui et al
In February 2024, a significant research article authored by Professor Gang An from Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, was published in the internationally recognized journal Haematologica (IF=11.047). The study, entitled “Minor clone of del(17p) provides a reservoir for relapse in multiple myeloma” marks…
-
Monitoring minimal residual disease in patients with multiple myeloma by targeted tracking serum M-protein using mass spectrometry (EasyM)
In a groundbreaking study conducted by a collaborative team including Professor Gang An from Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, their research “Monitoring minimal residual disease in patients with multiple myeloma by targeted tracking serum M-protein using mass spectrometry (EasyM)” has been brought to…
-
Early relapse within 18 months is a powerful dynamic predictor for prognosis and could revise static risk distribution in multiple myeloma
In February 2024, a study led by Professor Gang An from Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College was published in the international academic journal ——Cancer (IF=11.2). The title of the study is “Development and validation of an individualized and weighted Myeloma Prognostic Score System…
-
Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma
In January 2024, a study led by Professor Gang An from Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College was published in the international academic journal ——American Journal of Hematology(IF=12.8). The title of the study is “Development and validation of an individualized and weighted Myeloma Prognostic…
-
MAF translocation remains a strong prognostic factor despite concurrent chromosomal abnormalities
In January 2024, a groundbreaking study spearheaded by Professor Gang An from Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, made its debut in the esteemed journal Haematologica (IF=11.047). The research, titled “MAF translocation remains a strong prognostic factor despite concurrent chromosomal abnormalities” marks a significant…
-
Highlights of the Annual Conference | Dr. Jie Li: Comorbidity and Management of Diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD) in the New Era
The 21st National Conference on Viral Hepatitis and Hepatology, and the Annual Meetings of the Chinese Society of Hepatology and the Chinese Society of Infectious Diseases, took place from December 22nd to 24th, 2023, in Chengdu, Sichuan Province. This conference, co-hosted by the Chinese Medical Association, the Chinese Society of Hepatology, and the Chinese Society…
-
Expert Insight | Dr. XiaoheXiao: Precision Medication – Making Traditional Chinese Medicine the Guardian of the Body’s “Chemical Factory”
The liver, as the “chemical factory” of the human body, is responsible for the synthesis and metabolism of various crucial substances, while also serving as the “detoxification center” for harmful waste and toxins. However, the liver faces numerous challenges, including external factors such as viruses, bacteria, alcohol, drugs, and internal factors like self-consumption, immune imbalance,…
Connecting Medical Expertise through Media